---
$id: https://graph.org.ai/products/commodity/51201819
$type: Product
source: UNSPSC
code: "51201819"
title: "Sargramostim"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sargramostim

**UNSPSC Code**: 51201819
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic granulocyte-macrophage colony-stimulating factor with the molecular formula C639H1006N168O196S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5TAA004E22, more generally known as sargramostim. European Medicines Agency schedules sargramostim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10450MIG. The term SARGRAMOSTIM is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 6, no, 3 1992, list 32. SARGRAMOSTIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sargramostim under HS 30012010 and SITC 54162. As of Q4 2014, SARGRAMOSTIM remains the US FDA Preferred Term for this commodity. Sargramostim bears US NLM identifiers UMLS ID C0216231 and NCI Concept Code C1492. SMILES: C1CC(OC1CO)N2C=CC(=NC2=O)N.

